|
|
|
|
|
Neuro-Oncology
Reviews
|
|
|
|
Volume
27 Number 6
28 February 2025
|
|
|
|
Home
>
Publications
>
Neuro-Oncology
Reviews >
Volume
27, Year 2025 >
Number 6, 28
February
|
|
|
|
|
|
Chen B, Alder J.
A systematic review
of immunotherapies in combination with temozolomide as treatment
for glioblastoma.
Cancer
Treat Res Commun. 2025 Feb 24;43:100888. doi:
10.1016/j.ctarc.2025.100888. PMID:
40023003. Review. ˍ
|
|
|
|
Wach J, Vychopen M, Güresir E.
Prognostic
revalidation of RANO categories for extent of resection in
glioblastoma: a reconstruction of individual patient data.
J
Neurooncol. 2025 Feb 24. doi:
10.1007/s11060-025-04950-0. PMID:
39992571. Review. ˍ
|
|
|
|
D'Aprile S, Denaro S, Gervasi A, Vicario N, Parenti R.
Targeting
metabolic reprogramming in glioblastoma as a new strategy to
overcome therapy resistance.
Front
Cell Dev Biol. 2025 Feb 26;13:1535073. doi:
10.3389/fcell.2025.1535073. PMID:
40078366. Review. ˍ
|
|
|
|
Pouyan A, Ghorbanlo M, Eslami M, Jahanshahi M, Ziaei E, Salami A,
Mokhtari K, Shahpasand K, Farahani N, Meybodi TE, Entezari M,
Taheriazam A, Hushmandi K, Hashemi M.
Glioblastoma
multiforme: insights into pathogenesis, key signaling pathways,
and therapeutic strategies.
Mol
Cancer. 2025 Feb 26;24(1):58. doi:
10.1186/s12943-025-02267-0. PMID:
40011944. Review. ˍ
|
|
|
|
De Simone M, Choucha A, Ranalli C, Pecoraro G, Appay R, Chinot OL,
Dufour H, Iaconetta G.
Astrocytomas
IDH-mutant of posterior cranial fossa, clinical presentation,
imaging features and onco-functional balance in surgical
management.
Neurosurg
Rev. 2025 Feb 27;48(1):271. doi:
10.1007/s10143-025-03436-x. PMID:
40014162. Review. ˍ
|
|
|
|
Chieffo DPR, Marconi E, Zucchetti G, Montanaro M, Blom JMC, Poggi
G, Albino G, Sani L, Rostagno E, Ciappina S, Massimino M,
Mastronuzzi A, Scarponi D.
Pediatric
central nervous system (CNS) tumors cognitive and psychosocial
assessment: key highlights from the Italian (AIEOP) consensus
conference.
Child
Neuropsychol. 2025 Feb 27:1-15. doi:
10.1080/09297049.2025.2469723. PMID:
40017012. Meeting report˰
ˍ
|
|
|
|
Han H, Du A, Li J, Han H, Feng P, Zhu Y, Li X, Tian G, Yu H, Zhang
B, Liu W, Yuan G.
Transitioning from
molecular methods to therapeutic methods: An in-depth analysis of
glioblastoma (Review).
Oncol
Rep. 2025 Feb 27;53(4):48. doi:
10.3892/or.2025.8881. PMID:
40017136. Review. ˍ
|
|
|
|
Jang HJ, Park JW.
Microenvironmental
Drivers of Glioma Progression.
Int
J Mol Sci. 2025 Feb 27;26(5):2108. doi:
10.3390/ijms26052108. PMID:
40076738. Review. ˍ
|
|
|
|
Siegel BI, Patil P, Prakash A, Klawinski DM, Hwang EI.
Targeted
therapy in pediatric central nervous system tumors: a review from
the National Pediatric Cancer Foundation.
Front
Oncol. 2025 Feb 28;15:1504803. doi:
10.3389/fonc.2025.1504803. PMID:
40094009. Review. ˍ
|
|
|
|
|
|
|
|
|